Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Zambon

Showing results (41-50 of 141) with videos related to

Pageof 15
Sort By:
Environmental Toxicology and Chemistry|May 10, 2001
Assessment of chloroaniline toxicity by the submitochondrial particle assayE Argese, C Bettiol, F Agnoli, et al.
Frontiers in Molecular Neuroscience|August 28, 2020
LAMA2-Related Dystrophies: Clinical Phenotypes, Disease Biomarkers, and Clinical Trial ReadinessAnna Sarkozy, A Reghan Foley, Alberto A Zambon, et al.
The Journal of Organic Chemistry|April 17, 2001
Isolation and characterization of all eight bisadducts of fulleropyrrolidine derivativesK Kordatos, S Bosi, T Da Ros, et al.
Journal of Lipid Research|December 8, 2000
In vivo evidence of a role for hepatic lipase in human apoB-containing lipoprotein metabolism, independent of its lipolytic activityA Zambon, S S Deeb, A Bensadoun, et al.
Arquivos De Neuro-Psiquiatria|May 29, 1999
Myasthenia gravis and thymoma. Evaluation of 41 patientsJ L De Assis, A A Zambon, P S Souza, et al.
European Journal of Epidemiology|September 23, 1998
Exploring the combined action of lifetime alcohol intake and chronic hepatotropic virus infections on the risk of symptomatic liver cirrhosis. Collaborative Groups for the Study of Liver Diseases in ItalyG Corrao, P Torchio, A Zambon, et al.
The Cochrane Database of Systematic Reviews|April 23, 2005
School-based prevention for illicit drugs' useF Faggiano, F D Vigna-Taglianti, E Versino, et al.
Journal of Internal Medicine|April 6, 2006
Genetically determined apo B levels and peak LDL density predict angiographic response to intensive lipid-lowering therapyA Zambon, B G Brown, J E Hokanson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 1998
Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterolA Zambon, S S Deeb, J E Hokanson, et al.
Cancer Genetics and Cytogenetics|May 17, 2000
Anomalous transcripts and allelic deletions of the FHIT gene in human esophageal cancerC Menin, M Santacatterina, A Zambon, et al.
Pageof 15

Showing results (41-50 of 141) with videos related to

Sort By:
Pageof 15
Environmental Toxicology and Chemistry|May 10, 2001
Assessment of chloroaniline toxicity by the submitochondrial particle assayE Argese, C Bettiol, F Agnoli, et al.
Frontiers in Molecular Neuroscience|August 28, 2020
LAMA2-Related Dystrophies: Clinical Phenotypes, Disease Biomarkers, and Clinical Trial ReadinessAnna Sarkozy, A Reghan Foley, Alberto A Zambon, et al.
The Journal of Organic Chemistry|April 17, 2001
Isolation and characterization of all eight bisadducts of fulleropyrrolidine derivativesK Kordatos, S Bosi, T Da Ros, et al.
Journal of Lipid Research|December 8, 2000
In vivo evidence of a role for hepatic lipase in human apoB-containing lipoprotein metabolism, independent of its lipolytic activityA Zambon, S S Deeb, A Bensadoun, et al.
Arquivos De Neuro-Psiquiatria|May 29, 1999
Myasthenia gravis and thymoma. Evaluation of 41 patientsJ L De Assis, A A Zambon, P S Souza, et al.
European Journal of Epidemiology|September 23, 1998
Exploring the combined action of lifetime alcohol intake and chronic hepatotropic virus infections on the risk of symptomatic liver cirrhosis. Collaborative Groups for the Study of Liver Diseases in ItalyG Corrao, P Torchio, A Zambon, et al.
The Cochrane Database of Systematic Reviews|April 23, 2005
School-based prevention for illicit drugs' useF Faggiano, F D Vigna-Taglianti, E Versino, et al.
Journal of Internal Medicine|April 6, 2006
Genetically determined apo B levels and peak LDL density predict angiographic response to intensive lipid-lowering therapyA Zambon, B G Brown, J E Hokanson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 1998
Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterolA Zambon, S S Deeb, J E Hokanson, et al.
Cancer Genetics and Cytogenetics|May 17, 2000
Anomalous transcripts and allelic deletions of the FHIT gene in human esophageal cancerC Menin, M Santacatterina, A Zambon, et al.
Pageof 15